Drug Interactions between Fosrenol and valproic acid
This report displays the potential drug interactions for the following 2 drugs:
- Fosrenol (lanthanum carbonate)
- valproic acid
Interactions between your drugs
No interactions were found between Fosrenol and valproic acid. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Fosrenol
A total of 85 drugs are known to interact with Fosrenol.
- Fosrenol is in the drug class phosphate binders.
- Fosrenol is used to treat Hyperphosphatemia of Renal Failure.
valproic acid
A total of 404 drugs are known to interact with valproic acid.
- Valproic acid is in the drug class fatty acid derivative anticonvulsants.
-
Valproic acid is used to treat the following conditions:
- Bipolar Disorder
- Cluster-Tic Syndrome (off-label)
- Epilepsy
- Headache
- Hyperekplexia (off-label)
- Mania (off-label)
- Migraine
- Migraine Prevention
- Schizoaffective Disorder (off-label)
- Seizure Prevention
- Seizures
Drug and food interactions
valproic acid food
Applies to: valproic acid
GENERALLY AVOID: Alcohol may potentiate some of the pharmacologic effects of CNS-active agents. Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.
MANAGEMENT: Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol. Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.
References
- Warrington SJ, Ankier SI, Turner P (1986) "Evaluation of possible interactions between ethanol and trazodone or amitriptyline." Neuropsychobiology, 15, p. 31-7
- Gilman AG, eds., Nies AS, Rall TW, Taylor P (1990) "Goodman and Gilman's the Pharmacological Basis of Therapeutics." New York, NY: Pergamon Press Inc.
- (2012) "Product Information. Fycompa (perampanel)." Eisai Inc
- (2015) "Product Information. Rexulti (brexpiprazole)." Otsuka American Pharmaceuticals Inc
lanthanum carbonate food
Applies to: Fosrenol (lanthanum carbonate)
GENERALLY AVOID: Lanthanum carbonate should be administered with food for therapeutic efficacy. However, it is insoluble in water (<0.01 mg/mL at pH 7.5) and therefore cannot be dissolved in liquid for administration through an enteral feeding tube, because it may result in blockage of the tube.
MANAGEMENT: Administration of lanthanum carbonate with enteral feedings is not recommended. Alternative medications such as calcium carbonate suspension should be considered.
References
- Wohlt PD, Zheng L, Gunderson S, Balzar SA, Johnson BD, Fish JT (2009) "Recommendations for the use of medications with continuous enteral nutrition." Am J Health Syst Pharm, 66, p. 1438-67
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.